| Aurobindo Pharma Limited | 1,252 | 1,252G/0B | $0.6136 | -0.52% | 438↑ 586↓of 1024 | 2 | 17 |
| Sun Pharmaceutical Industries Inc. | 933 | 904G/29B | $3.0097 | -0.37% | 233↑ 326↓of 559 | 10 | 24 |
| NorthStar Rx LLC | 899 | 899G/0B | $1.5718 | -0.89% | 339↑ 486↓of 825 | 1 | 8 |
| Teva Pharmaceuticals USA Inc. | 812 | 795G/17B | $67.1555 | -0.56% | 304↑ 448↓of 752 | 4 | 13 |
| Rising Pharma Holdings Inc. | 764 | 763G/1B | $0.7060 | -0.38% | 304↑ 404↓of 708 | 1 | 7 |
| Major Pharmaceuticals | 734 | 734G/0B | $0.2733 | -0.36% | 297↑ 378↓of 675 | 25 | 7 |
| Dr. Reddy's Laboratories Inc. | 701 | 701G/0B | $2.2047 | -1.10% | 230↑ 328↓of 558 | 3 | 8 |
| Camber Pharmaceuticals Inc. | 668 | 668G/0B | $1.2182 | -0.98% | 256↑ 351↓of 607 | 1 | 7 |
| American Health Packaging | 639 | 638G/1B | $0.3504 | -0.50% | 246↑ 362↓of 608 | 32 | 2 |
| Mylan Pharmaceuticals Inc. | 628 | 623G/5B | $2.6650 | -0.34% | 237↑ 333↓of 570 | 7 | 10 |
| Zydus Pharmaceuticals (USA) Inc. | 625 | 618G/7B | $1.5453 | -0.93% | 222↑ 340↓of 562 | 2 | 9 |
| Lupin Pharmaceuticals Inc. | 557 | 552G/5B | $4.9985 | -0.79% | 163↑ 257↓of 420 | 3 | 14 |
| Alembic Pharmaceuticals Inc. | 523 | 523G/0B | $0.9666 | -0.74% | 215↑ 281↓of 496 | 2 | 2 |
| Chartwell RX LLC | 521 | 521G/0B | $0.5306 | -0.27% | 215↑ 284↓of 499 | 4 | 9 |
| Ascend Laboratories, LLC | 461 | 461G/0B | $1.1368 | -1.28% | 154↑ 248↓of 402 | — | 5 |
| Glenmark Pharmaceuticals Inc., USA | 444 | 444G/0B | $1.5857 | -0.30% | 155↑ 197↓of 352 | 2 | 8 |
| Actavis Pharma, Inc. | 439 | 438G/1B | $1.0502 | -0.74% | 147↑ 218↓of 365 | 1 | 11 |
| Strategic Sourcing Services LLC | 431 | 431G/0B | $0.2718 | -0.29% | 126↑ 163↓of 289 | 2 | 4 |
| Cardinal Health | 420 | 420G/0B | $0.1970 | +0.04% | 164↑ 164↓of 328 | 4 | 2 |
| Macleods Pharmaceuticals Limited | 418 | 418G/0B | $0.4525 | -0.80% | 170↑ 198↓of 368 | — | 1 |
| Hikma Pharmaceuticals USA Inc. | 414 | 414G/0B | $2.6026 | -0.11% | 139↑ 172↓of 311 | 2 | 4 |
| BluePoint Laboratories | 395 | 395G/0B | $2.8817 | -0.46% | 133↑ 199↓of 332 | 2 | 2 |
| Sandoz Inc. | 394 | 351G/43B | $22.2539 | +0.10% | 142↑ 167↓of 309 | 4 | 10 |
| AmerisourceBergen | 393 | 393G/0B | $0.3056 | -0.32% | 132↑ 192↓of 324 | — | 2 |
| Amneal Pharmaceuticals LLC | 388 | 359G/29B | $4.3481 | -0.04% | 121↑ 129↓of 250 | 2 | 16 |
| Solco Healthcare US LLC | 365 | 365G/0B | $0.2172 | -0.23% | 152↑ 195↓of 347 | 1 | 2 |
| Apotex Corp. | 362 | 350G/12B | $5.3293 | -1.18% | 130↑ 186↓of 316 | — | 9 |
| Heritage Pharmaceuticals Inc. | 317 | 317G/0B | $0.4605 | -0.45% | 111↑ 178↓of 289 | 1 | 9 |
| Accord Healthcare Inc. | 316 | 316G/0B | $0.6903 | -0.81% | 35↑ 52↓of 87 | 1 | 13 |
| Torrent Pharmaceuticals Limited | 315 | 315G/0B | $1.9375 | +0.34% | 148↑ 115↓of 263 | — | 2 |
| Cipla USA Inc. | 308 | 308G/0B | $1.5741 | -0.86% | 85↑ 120↓of 205 | 1 | 7 |
| Unichem Pharmaceuticals (USA) Inc. | 306 | 306G/0B | $0.1336 | -0.08% | 135↑ 147↓of 282 | — | 3 |
| Amneal Pharmaceuticals NY LLC | 306 | 306G/0B | $3.6012 | -0.44% | 119↑ 144↓of 263 | — | 8 |
| Upsher-Smith Laboratories LLC | 305 | 263G/42B | $3.1806 | +0.21% | 111↑ 113↓of 224 | — | 12 |
| AvPAK | 300 | 300G/0B | $0.2319 | -0.38% | 127↑ 166↓of 293 | 6 | 1 |
| ANI Pharmaceuticals, Inc. | 296 | 279G/17B | $3.1063 | -1.27% | 119↑ 146↓of 265 | 2 | 13 |
| Exelan Pharmaceuticals Inc. | 285 | 285G/0B | $0.2235 | -0.34% | 108↑ 154↓of 262 | — | — |
| Advagen Pharma Ltd. | 278 | 278G/0B | $0.4028 | -0.15% | 136↑ 142↓of 278 | — | 3 |
| Amneal Pharmaceuticals of New York LLC | 263 | 263G/0B | $3.0811 | -0.43% | 60↑ 88↓of 148 | — | 7 |
| Westminster Pharmaceuticals LLC | 263 | 263G/0B | $0.2851 | +0.11% | 128↑ 122↓of 250 | — | 1 |
| Padagis Israel Pharmaceuticals Ltd | 261 | 259G/2B | $3.3134 | -0.15% | 126↑ 120↓of 246 | — | 9 |
| Lannett Company Inc. | 258 | 258G/0B | $0.7902 | -0.43% | 89↑ 111↓of 200 | — | 6 |
| Strides Pharma Inc. | 247 | 247G/0B | $0.4185 | +0.39% | 101↑ 110↓of 211 | 1 | 3 |
| Epic Pharma LLC | 243 | 243G/0B | $0.4256 | -0.51% | 79↑ 125↓of 204 | 1 | 1 |
| Chain Drug Marketing Association | 227 | 227G/0B | $0.1226 | +0.04% | 59↑ 67↓of 126 | 4 | 3 |
| Endo USA Inc. | 219 | 204G/15B | $7.4602 | -0.80% | 87↑ 116↓of 203 | — | 8 |
| Granules Pharmaceuticals Inc. | 209 | 209G/0B | $0.5760 | -1.08% | 60↑ 136↓of 196 | — | 2 |
| Rugby Laboratories | 209 | 209G/0B | $0.4334 | -0.32% | 75↑ 109↓of 184 | 3 | 3 |
| Haleon US Holdings LLC | 203 | 0G/203B | $0.5315 | — | — | — | 8 |
| Ajanta Pharma USA Inc. | 194 | 194G/0B | $0.8248 | -0.11% | 80↑ 78↓of 158 | — | 5 |
| Novadoz Pharmaceuticals LLC | 191 | 191G/0B | $2.6108 | -1.40% | 64↑ 114↓of 178 | 3 | 2 |
| SpecGx LLC | 173 | 168G/5B | $1.6115 | +0.28% | 76↑ 79↓of 155 | — | 2 |
| L. Perrigo Company | 167 | 161G/6B | $0.2685 | -0.25% | 61↑ 96↓of 157 | — | 1 |
| Fresenius Kabi USA, LLC | 165 | 157G/8B | $24.5904 | -0.42% | 39↑ 55↓of 94 | — | 2 |
| Mylan Institutional LLC | 149 | 147G/2B | $25.2297 | +0.48% | 51↑ 73↓of 124 | 5 | — |
| Lifestar Pharma LLC | 148 | 148G/0B | $0.9410 | -0.46% | 49↑ 77↓of 126 | 2 | 1 |
| Quallent Pharmaceuticals Health LLC | 147 | 147G/0B | $4.5573 | -0.33% | 63↑ 82↓of 145 | 1 | 2 |
| Allergan, Inc. | 146 | 0G/146B | $40.6121 | -0.03% | 22↑ 59↓of 81 | — | 17 |
| Ingenus Pharmaceuticals LLC | 144 | 141G/3B | $3.7036 | +0.18% | 67↑ 59↓of 126 | 1 | 4 |
| Nivagen Pharmaceuticals Inc. | 137 | 137G/0B | $0.8551 | -0.46% | 27↑ 37↓of 64 | 2 | 5 |
| Viona Pharmaceuticals Inc. | 133 | 133G/0B | $0.4940 | +0.28% | 58↑ 73↓of 131 | — | 2 |
| Bionpharma Inc. | 131 | 131G/0B | $0.6192 | -0.52% | 44↑ 81↓of 125 | 2 | 1 |
| KVK-Tech Inc. | 130 | 130G/0B | $0.5250 | +0.63% | 41↑ 46↓of 87 | — | 4 |
| Cosette Pharmaceuticals, Inc. | 128 | 108G/20B | $4.1884 | -0.18% | 53↑ 52↓of 105 | — | 6 |
| Leading Pharma, LLC | 125 | 125G/0B | $0.8722 | -0.14% | 46↑ 56↓of 102 | 1 | 4 |
| ScieGen Pharmaceuticals, Inc. | 122 | 122G/0B | $0.0952 | -0.40% | 41↑ 78↓of 119 | — | 1 |
| Micro Labs Limited | 120 | 120G/0B | $0.6849 | -0.51% | 47↑ 54↓of 101 | 2 | 1 |
| Hospira Inc. | 119 | 117G/2B | $4.3012 | +0.18% | 20↑ 24↓of 44 | 2 | 3 |
| Jubilant Cadista Pharmaceuticals Inc. | 119 | 119G/0B | $0.2294 | -0.66% | 21↑ 43↓of 64 | — | 3 |
| Pfizer Inc. | 118 | 0G/118B | $62.7890 | +0.02% | 24↑ 25↓of 49 | — | 19 |
| RB Health (US) LLC | 110 | 0G/110B | $0.4154 | — | — | — | 5 |
| Method Pharmaceuticals LLC | 110 | 110G/0B | $0.2667 | +0.36% | 44↑ 48↓of 92 | — | 1 |
| Oceanside Pharmaceuticals | 108 | 108G/0B | $10.9894 | — | — | — | 5 |
| Bausch Health US LLC | 104 | 3G/101B | $34.0775 | — | — | — | 19 |
| Prasco Laboratories | 103 | 103G/0B | $14.6343 | -0.40% | 32↑ 61↓of 93 | — | 1 |
| Aurolife Pharma LLC | 99 | 99G/0B | $0.2520 | +0.07% | 35↑ 56↓of 91 | — | — |
| Taro Pharmaceuticals U.S.A. Inc. | 98 | 97G/1B | $0.8343 | -0.74% | 34↑ 29↓of 63 | — | 1 |
| Rhodes Pharmaceuticals L.P. | 97 | 83G/14B | $4.0963 | +0.51% | 37↑ 30↓of 67 | 1 | 1 |
| Viatris Specialty LLC | 95 | 4G/91B | $26.1990 | -0.12% | 25↑ 31↓of 56 | — | 21 |
| Slate Run Pharmaceuticals LLC | 94 | 94G/0B | $1.3328 | -1.88% | 15↑ 21↓of 36 | 1 | 2 |
| Alvogen Inc. | 94 | 94G/0B | $14.1995 | -0.94% | 31↑ 46↓of 77 | — | 2 |
| TruPharma LLC | 94 | 94G/0B | $1.0131 | -0.19% | 38↑ 42↓of 80 | — | 6 |
| Somerset Therapeutics, LLC | 93 | 93G/0B | $5.2273 | +0.57% | 38↑ 47↓of 85 | 1 | 1 |
| Biocon Pharma Inc. | 93 | 93G/0B | $2.4410 | -0.85% | 33↑ 53↓of 86 | — | 1 |
| Novartis Pharmaceuticals Corporation | 92 | 0G/92B | $766.91 | -0.03% | 16↑ 17↓of 33 | — | 15 |
| ScieGen Pharmaceuticals Inc. | 91 | 91G/0B | $0.2157 | +0.21% | 58↑ 31↓of 89 | — | — |
| Merck Sharp & Dohme LLC | 89 | 0G/89B | $84.7495 | — | 21↑ 31↓of 52 | — | 5 |
| Encube Ethicals, Inc. | 88 | 88G/0B | $0.8887 | +0.02% | 49↑ 36↓of 85 | — | — |
| AbbVie Inc. | 88 | 1G/87B | $1245.79 | +0.01% | 22↑ 34↓of 56 | — | 5 |
| Xiromed LLC | 88 | 88G/0B | $3.5059 | -0.91% | 37↑ 44↓of 81 | — | — |
| Time-Cap Labs Inc. | 86 | 86G/0B | $0.0805 | +0.14% | 36↑ 47↓of 83 | — | — |
| Bausch & Lomb Incorporated | 86 | 55G/31B | $21.5801 | +0.84% | 32↑ 23↓of 55 | 1 | 8 |
| Topco Associates LLC | 86 | 86G/0B | $0.3786 | — | — | 4 | 2 |
| Breckenridge Pharmaceutical Inc. | 85 | 85G/0B | $1.8401 | +0.23% | 54↑ 26↓of 80 | — | — |
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 82 | 82G/0B | $0.5569 | +1.58% | 33↑ 24↓of 57 | — | — |
| Oxford Pharmaceuticals, LLC | 82 | 82G/0B | $0.0735 | -0.64% | 30↑ 51↓of 81 | — | — |
| Takeda Pharmaceuticals America, Inc. | 80 | 1G/79B | $29.7720 | -0.04% | 16↑ 30↓of 46 | — | 14 |
| Mayne Pharma | 78 | 65G/13B | $33.6469 | +0.60% | 17↑ 16↓of 33 | 2 | 6 |
| Sagent Pharmaceuticals | 78 | 78G/0B | $6.6031 | +0.33% | 23↑ 23↓of 46 | — | — |
| Eli Lilly and Company | 77 | 4G/73B | $629.84 | -0.02% | 13↑ 22↓of 35 | — | 4 |
| Modavar Pharmaceuticals LLC | 75 | 75G/0B | $0.1421 | +0.51% | 42↑ 33↓of 75 | — | — |
| Boehringer Ingelheim Pharmaceuticals Inc. | 73 | 1G/72B | $69.7095 | -0.02% | 10↑ 51↓of 61 | — | 3 |
| Janssen Pharmaceuticals Inc. | 70 | 0G/70B | $580.01 | +0.01% | 15↑ 33↓of 48 | — | 5 |
| Padagis US LLC | 70 | 68G/2B | $7.5339 | -1.31% | 26↑ 35↓of 61 | — | 6 |
| Legacy Pharmaceutical Packaging, LLC | 68 | 68G/0B | $0.0449 | +0.02% | 29↑ 39↓of 68 | 3 | 2 |
| AstraZeneca Pharmaceuticals LP | 67 | 2G/65B | $38.5024 | -0.12% | 12↑ 28↓of 40 | — | 6 |
| GlaxoSmithKline LLC | 67 | 0G/67B | $34.6316 | — | 14↑ 26↓of 40 | — | 6 |
| Eugia US LLC | 67 | 67G/0B | $12.9535 | -1.06% | 15↑ 23↓of 38 | 1 | 1 |
| Meitheal Pharmaceuticals Inc. | 63 | 62G/1B | $23.0143 | -0.47% | 15↑ 27↓of 42 | — | — |
| Organon LLC | 62 | 1G/61B | $76.2876 | +0.03% | 13↑ 19↓of 32 | — | 14 |
| PAI Holdings LLC | 60 | 60G/0B | $4.2520 | +1.07% | 26↑ 23↓of 49 | 3 | 2 |
| PuraCap Laboratories LLC | 59 | 59G/0B | $0.6444 | +0.38% | 17↑ 33↓of 50 | 1 | — |
| Carlsbad Technology Inc. | 56 | 56G/0B | $0.1073 | -1.20% | 11↑ 39↓of 50 | — | — |
| Camber Consumer Care | 56 | 56G/0B | $0.1593 | -0.61% | 19↑ 34↓of 53 | — | — |
| Cranbury Pharmaceuticals, LLC | 56 | 56G/0B | $0.1681 | -0.45% | 16↑ 37↓of 53 | 1 | 1 |
| Novo Nordisk | 55 | 8G/47B | $181.61 | -0.02% | 12↑ 19↓of 31 | — | 1 |
| Pharmacia & Upjohn Company LLC | 55 | 0G/55B | $25.1754 | +1.09% | 11↑ 9↓of 20 | — | 9 |
| Sanofi-Aventis U.S. LLC | 54 | 17G/37B | $200.16 | -0.56% | 9↑ 20↓of 29 | — | 7 |
| Eywa Pharma Inc | 51 | 51G/0B | $0.4339 | +0.99% | 18↑ 17↓of 35 | — | — |
| McKesson | 50 | 50G/0B | $0.3366 | -1.10% | 5↑ 15↓of 20 | 4 | — |
| Laurus Labs Limited | 50 | 50G/0B | $0.3542 | -1.13% | 15↑ 31↓of 46 | — | — |
| Precision Dose Inc. | 48 | 48G/0B | $0.3867 | -1.14% | 9↑ 35↓of 44 | 1 | 1 |
| Alcon Laboratories, Inc. | 48 | 4G/44B | $12.1354 | +0.01% | 13↑ 23↓of 36 | — | 3 |
| Acella Pharmaceuticals, LLC | 48 | 48G/0B | $1.0261 | -0.31% | 19↑ 20↓of 39 | — | 2 |
| Florida Pharmaceutical Products, LLC | 48 | 48G/0B | $1.1732 | -2.39% | 11↑ 23↓of 34 | — | 1 |
| Bayer HealthCare LLC | 47 | 0G/47B | $0.5913 | — | — | — | 3 |
| Edenbridge Pharmaceuticals LLC | 46 | 46G/0B | $0.8433 | +1.15% | 24↑ 18↓of 42 | — | 1 |
| Elite Laboratories, Inc. | 46 | 46G/0B | $0.7874 | -0.38% | 20↑ 26↓of 46 | — | — |
| Trigen Laboratories, LLC | 45 | 45G/0B | $3.7199 | -1.70% | 24↑ 19↓of 43 | 1 | 2 |
| Quagen Pharmaceuticals LLC | 44 | 44G/0B | $0.3497 | +0.95% | 24↑ 17↓of 41 | — | — |
| Wilshire Pharmaceuticals Inc. | 42 | 42G/0B | $2.4148 | +3.37% | 22↑ 17↓of 39 | — | 1 |
| Par Health USA, LLC | 42 | 39G/3B | $3.7580 | -0.92% | 16↑ 19↓of 35 | — | 1 |
| Ohm Laboratories Inc. | 40 | 40G/0B | $0.2539 | -1.11% | 13↑ 21↓of 34 | — | 1 |
| Winder Laboratories LLC | 40 | 40G/0B | $0.9732 | +1.50% | 24↑ 13↓of 37 | — | — |
| Apnar Pharma LP | 37 | 37G/0B | $0.1400 | -0.58% | 15↑ 19↓of 34 | — | — |
| Mullan Pharmaceutical Inc. | 37 | 37G/0B | $1.7971 | -1.02% | 12↑ 24↓of 36 | — | — |
| UCB, Inc. | 37 | 0G/37B | $1006.53 | — | 17↑ 14↓of 31 | — | 3 |
| Sunrise Pharmaceutical Inc. | 37 | 37G/0B | $0.1795 | +0.63% | 23↑ 11↓of 34 | — | 1 |
| ACI Healthcare USA, Inc. | 36 | 36G/0B | $0.0608 | -0.25% | 10↑ 7↓of 17 | — | — |
| Baxter Healthcare Corporation | 35 | 35G/0B | $8.3629 | +0.44% | 8↑ 6↓of 14 | 1 | 1 |
| Vitruvias Therapeutics Inc. | 34 | 34G/0B | $2.2299 | -1.77% | 13↑ 17↓of 30 | — | — |
| Azurity Pharmaceuticals Inc. | 34 | 1G/33B | $5.7887 | -0.03% | 4↑ 12↓of 16 | 1 | 8 |
| Burel Pharmaceuticals, LLC | 33 | 33G/0B | $0.6064 | +0.17% | 13↑ 16↓of 29 | 1 | — |
| Amici Pharmaceuticals LLC | 32 | 32G/0B | $0.6809 | +0.35% | 8↑ 22↓of 30 | — | — |
| Amgen Inc. | 32 | 0G/32B | $875.29 | -0.01% | 3↑ 6↓of 9 | — | 1 |
| IBSA Pharma Inc. | 31 | 0G/31B | $5.3518 | — | — | — | 1 |
| Ritedose Pharmaceuticals, LLC | 30 | 30G/0B | $0.3341 | -1.06% | 8↑ 22↓of 30 | — | — |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 30 | 0G/30B | $10.5371 | -0.01% | 9↑ 13↓of 22 | — | 3 |
| TAGI Pharma Inc. | 29 | 29G/0B | $0.2435 | — | — | 1 | 1 |
| Civica, Inc. | 28 | 28G/0B | $3.5756 | +2.17% | 13↑ 6↓of 19 | — | — |
| Bayer HealthCare Pharmaceuticals Inc. | 28 | 0G/28B | $45.3876 | — | 12↑ 13↓of 25 | — | 1 |
| Otsuka America Pharmaceutical Inc. | 27 | 0G/27B | $721.17 | -0.04% | 7↑ 12↓of 19 | — | 2 |
| Novitium Pharma LLC | 27 | 27G/0B | $0.4890 | -0.59% | 7↑ 19↓of 26 | — | 1 |
| SOLA Pharmaceuticals LLC | 26 | 26G/0B | $1.0185 | +0.49% | 14↑ 11↓of 25 | — | — |
| Atlantis Consumer Healthcare, Inc. | 26 | 3G/23B | $0.2204 | -0.57% | 0↑ 11↓of 11 | — | 1 |
| Sigmapharm Laboratories LLC | 26 | 26G/0B | $3.1268 | -0.92% | 11↑ 14↓of 25 | 1 | — |
| Purdue Pharma LP | 25 | 0G/25B | $35.6080 | -0.01% | 9↑ 10↓of 19 | — | 1 |
| Galderma Laboratories, L.P. | 25 | 0G/25B | $11.4656 | +1.04% | 4↑ 1↓of 5 | — | 8 |
| Nephron Pharmaceuticals Corporation | 24 | 23G/1B | $0.2603 | -0.82% | 6↑ 13↓of 19 | — | — |
| Fosun Pharma USA Inc. | 24 | 24G/0B | $8.6835 | -1.96% | 8↑ 12↓of 20 | — | — |
| Ipca Laboratories Limited | 24 | 24G/0B | $0.0758 | -1.56% | 1↑ 23↓of 24 | — | — |
| Pacific Pharma, Inc. | 24 | 24G/0B | $5.6243 | +0.24% | 12↑ 10↓of 22 | — | 1 |
| E.R. Squibb & Sons, L.L.C. | 24 | 0G/24B | $177.80 | -0.02% | 6↑ 9↓of 15 | — | 3 |
| Noven Therapeutics, LLC | 23 | 5G/18B | $17.2712 | +0.97% | 10↑ 5↓of 15 | — | — |
| H2-Pharma LLC | 22 | 10G/12B | $25.2877 | -0.96% | 5↑ 7↓of 12 | 1 | 2 |
| Caplin Steriles Limited | 22 | 22G/0B | $2.7837 | +0.64% | 9↑ 10↓of 19 | — | 1 |
| Genus Lifesciences Inc. | 22 | 19G/3B | $1.5350 | -0.80% | 6↑ 10↓of 16 | — | 3 |
| Aarna USA Inc. | 21 | 21G/0B | $0.1307 | -0.98% | 8↑ 13↓of 21 | — | — |
| Almatica Pharma LLC | 21 | 7G/14B | $10.6088 | -1.89% | 3↑ 10↓of 13 | — | 8 |
| Devatis Inc. | 20 | 20G/0B | $5.3437 | -0.20% | 6↑ 5↓of 11 | — | — |
| American Regent, Inc. | 20 | 17G/3B | $8.5043 | +0.10% | 5↑ 6↓of 11 | — | 2 |
| WG Critical Care, LLC | 19 | 19G/0B | $6.8183 | -1.18% | 4↑ 3↓of 7 | — | 1 |
| Amphastar Pharmaceuticals, Inc. | 19 | 17G/2B | $80.3432 | +0.05% | 4↑ 9↓of 13 | — | — |
| Yiling Pharmaceutical Inc. | 19 | 19G/0B | $0.1560 | — | — | — | — |
| The Procter & Gamble Manufacturing Company | 18 | 0G/18B | $0.2947 | — | — | — | — |
| Astellas Pharma US, Inc. | 18 | 0G/18B | $17.5034 | — | 4↑ 6↓of 10 | — | 2 |
| Gilead Sciences, Inc. | 18 | 0G/18B | $286.53 | -0.02% | 4↑ 4↓of 8 | — | 2 |
| Oryza Pharmaceuticals Inc. | 18 | 18G/0B | $0.1364 | -1.59% | 7↑ 11↓of 18 | — | — |
| Neolpharma, Inc. | 17 | 17G/0B | $0.0558 | -2.43% | 4↑ 13↓of 17 | — | — |
| Reliable 1 Laboratories LLC | 17 | 17G/0B | $0.0268 | — | — | — | — |
| Vertical Pharmaceuticals, LLC | 17 | 3G/14B | $8.2854 | +0.02% | 3↑ 1↓of 4 | — | 2 |
| Amici Pharma, Inc | 16 | 16G/0B | $0.5034 | +2.23% | 13↑ 3↓of 16 | — | — |
| Tris Pharma Inc | 16 | 16G/0B | $0.3463 | -6.70% | 0↑ 6↓of 6 | — | 1 |
| Teva Neuroscience, Inc. | 16 | 0G/16B | $244.75 | -0.11% | 4↑ 8↓of 12 | — | 1 |
| Vensun Pharmaceuticals, Inc. | 15 | 15G/0B | $0.0549 | — | — | — | — |
| Seton Pharmaceuticals | 15 | 15G/0B | $21.3656 | — | — | — | — |
| Sumitomo Pharma America, Inc. | 15 | 0G/15B | $42.4046 | -0.07% | 2↑ 5↓of 7 | — | 2 |
| e5 Pharma, LLC | 15 | 15G/0B | $0.5895 | +2.82% | 13↑ 2↓of 15 | — | — |
| Eisai Inc. | 15 | 0G/15B | $22.0894 | -0.05% | 4↑ 7↓of 11 | — | 2 |
| Xellia Pharmaceuticals USA LLC | 15 | 15G/0B | $12.0604 | +3.54% | 2↑ 2↓of 4 | — | — |
| Genentech, Inc. | 15 | 0G/15B | $196.51 | -0.22% | 1↑ 3↓of 4 | — | 2 |
| Bausch & Lomb Americas Inc. | 15 | 15G/0B | $12.9569 | +1.94% | 7↑ 8↓of 15 | — | 1 |
| B. Braun Medical Inc. | 15 | 15G/0B | $0.0047 | +1.88% | 3↑ 0↓of 3 | — | — |
| Natco Pharma USA LLC | 15 | 15G/0B | $0.3072 | -1.31% | 2↑ 11↓of 13 | — | — |
| Neos Therapeutics Brands, LLC | 15 | 6G/9B | $16.7511 | -0.07% | 4↑ 8↓of 12 | — | 1 |
| Armas Pharmaceuticals Inc. | 15 | 15G/0B | $1.5689 | -2.24% | 2↑ 5↓of 7 | 1 | 1 |
| Trifluent Pharma LLC | 15 | 15G/0B | $6.0834 | -1.14% | 6↑ 7↓of 13 | — | 2 |
| Salix Pharmaceuticals Inc. | 15 | 0G/15B | $105.14 | — | — | — | 1 |
| Supernus Pharmaceuticals Inc. | 15 | 0G/15B | $20.4762 | -0.02% | 1↑ 6↓of 7 | — | 1 |
| Solaris Pharma Corporation | 14 | 14G/0B | $1.9504 | -0.94% | 8↑ 6↓of 14 | — | — |
| Xttrium Laboratories, Inc. | 14 | 10G/4B | $0.0423 | +0.19% | 9↑ 3↓of 12 | — | — |
| YARAL Pharma Inc. | 14 | 14G/0B | $2.6555 | — | — | — | — |
| Archis Pharma LLC | 14 | 14G/0B | $0.7242 | -2.65% | 3↑ 11↓of 14 | — | — |
| Saptalis Pharmaceuticals LLC | 13 | 11G/2B | $0.9385 | +0.67% | 6↑ 7↓of 13 | — | 1 |
| Provell Pharmaceuticals, LLC | 13 | 0G/13B | $0.1719 | — | — | — | — |
| Janssen Products LP | 13 | 0G/13B | $190.26 | -0.06% | 0↑ 3↓of 3 | — | 2 |
| Llorens Pharmaceutical International Division | 13 | 13G/0B | $0.0984 | -1.20% | 3↑ 4↓of 7 | — | — |
| BE Pharmaceuticals Inc. | 13 | 13G/0B | $10.6226 | -0.46% | 3↑ 6↓of 9 | — | — |
| ViiV Healthcare Company | 13 | 0G/13B | $60.6145 | -0.07% | 2↑ 3↓of 5 | — | 3 |
| NextWave Pharmaceuticals, Inc | 13 | 0G/13B | $8.9344 | — | 4↑ 7↓of 11 | — | 1 |
| Pharbest Pharmaceuticals, Inc. | 13 | 13G/0B | $0.0255 | — | — | — | — |
| Innogenix, Inc. | 13 | 13G/0B | $0.1626 | — | — | — | — |
| USAntibiotics, LLC | 13 | 13G/0B | $0.1797 | +1.75% | 11↑ 2↓of 13 | — | — |
| Collegium Pharmaceutical, Inc. | 13 | 0G/13B | $17.5109 | — | — | — | — |
| Afaxys Pharma, LLC | 13 | 13G/0B | $0.6127 | +0.25% | 7↑ 6↓of 13 | — | — |
| Patrin Pharma Inc. | 12 | 12G/0B | $0.4575 | +1.07% | 6↑ 4↓of 10 | 1 | 1 |
| Mission Pharmacal Company | 12 | 2G/10B | $4.3282 | -1.12% | 0↑ 1↓of 1 | — | 3 |
| Nordic Pharma, Inc. | 12 | 12G/0B | $5.9569 | -0.84% | 4↑ 8↓of 12 | — | — |
| i3 Pharmaceuticals, LLC | 12 | 12G/0B | $1.8431 | -1.51% | 4↑ 7↓of 11 | — | — |
| Roerig | 12 | 0G/12B | $23.0818 | +0.01% | 1↑ 1↓of 2 | — | 3 |
| Poly Pharmaceuticals, Inc. | 11 | 11G/0B | $0.5265 | -0.11% | 0↑ 2↓of 2 | — | — |
| C.B. Fleet Company, Inc. | 11 | 0G/11B | $0.1011 | — | — | — | 2 |
| Zameer Pharmaceuticals LLC | 11 | 11G/0B | $0.6891 | -0.37% | 1↑ 1↓of 2 | — | 3 |
| Crown Laboratories | 11 | 9G/2B | $0.2542 | — | — | — | 1 |
| CarWin Pharmaceutical Associates LLC | 11 | 2G/9B | $14.9149 | -2.96% | 2↑ 2↓of 4 | — | 3 |
| Larken Laboratories, Inc. | 11 | 11G/0B | $0.2110 | -1.15% | 4↑ 5↓of 9 | — | — |
| Edwards Pharmaceuticals, Inc. | 11 | 10G/1B | $0.8391 | -1.64% | 3↑ 4↓of 7 | — | — |
| Arbor Pharmaceuticals, Inc. | 11 | 11G/0B | $3.6606 | -1.64% | 2↑ 2↓of 4 | — | — |
| Novugen Pharma (USA) LLC | 11 | 11G/0B | $0.6475 | +0.43% | 9↑ 2↓of 11 | — | — |
| TWi Pharmaceuticals, Inc. | 11 | 11G/0B | $0.1389 | -2.15% | 2↑ 3↓of 5 | — | — |
| Aimmune Therapeutics, Inc. | 10 | 0G/10B | $8.5787 | -0.04% | 2↑ 5↓of 7 | — | — |
| Cambridge Therapeutics Technologies, LLC | 10 | 10G/0B | $0.2930 | — | — | — | 1 |
| Teva Parenteral Medicines, Inc. | 10 | 10G/0B | $2.7945 | +0.42% | 2↑ 3↓of 5 | — | 1 |
| Exeltis USA, Inc. | 10 | 0G/10B | $7.7860 | -0.02% | 2↑ 6↓of 8 | — | 1 |
| VistaPharm, LLC | 10 | 10G/0B | $0.7895 | -1.65% | 4↑ 4↓of 8 | 1 | 1 |
| Alkermes, Inc. | 10 | 0G/10B | $697.46 | +0.31% | 5↑ 4↓of 9 | — | — |
| Currax Pharmaceuticals LLC | 10 | 3G/7B | $24.6196 | — | — | — | 1 |
| Janssen Biotech, Inc. | 10 | 0G/10B | $13101.80 | +0.07% | 3↑ 1↓of 4 | — | 1 |
| CivicaScript LLC | 10 | 10G/0B | $0.7190 | -1.13% | 3↑ 6↓of 9 | — | — |
| SK Life Science, Inc. | 10 | 0G/10B | $35.3084 | +0.09% | 6↑ 1↓of 7 | — | — |
| Hepalink USA Inc. | 10 | 10G/0B | $7.0122 | -2.53% | 1↑ 8↓of 9 | — | — |
| Sheffield Pharmaceuticals LLC | 10 | 10G/0B | $0.1002 | -0.04% | 3↑ 7↓of 10 | — | — |
| EMD Serono, Inc. | 9 | 0G/9B | $1430.03 | +0.04% | 1↑ 0↓of 1 | — | — |
| Apozeal Pharmaceuticals Inc. | 9 | 9G/0B | $0.0444 | -0.31% | 3↑ 6↓of 9 | — | — |
| Axsome Therapeutics, Inc. | 9 | 0G/9B | $38.1484 | +0.08% | 5↑ 0↓of 5 | — | — |
| Carnegie Pharmaceuticals LLC | 9 | 7G/2B | $1.2959 | -2.06% | 3↑ 4↓of 7 | — | — |
| International Medication Systems, Limited | 9 | 9G/0B | $5.0874 | -1.40% | 3↑ 3↓of 6 | — | 1 |
| Virtus Pharmaceuticals, LLC | 9 | 9G/0B | $2.1778 | -1.67% | 0↑ 7↓of 7 | — | 2 |
| Person and Covey | 9 | 4G/5B | $0.0990 | -0.10% | 1↑ 1↓of 2 | — | — |
| XGen Pharmaceuticals DJB, Inc. | 9 | 9G/0B | $10.6300 | +0.12% | 2↑ 3↓of 5 | — | — |
| Nomax Inc. | 9 | 9G/0B | $0.4149 | -0.38% | 2↑ 7↓of 9 | — | — |
| Antares Pharma, Inc. | 9 | 0G/9B | $325.28 | -0.01% | 2↑ 2↓of 4 | — | 1 |
| Avet Pharmaceuticals Inc. | 9 | 9G/0B | $1.0112 | -0.13% | 7↑ 1↓of 8 | — | — |
| CMP Pharma, Inc. | 9 | 5G/4B | $2.4695 | -0.36% | 5↑ 1↓of 6 | 1 | 1 |
| Avion Pharmaceuticals, LLC | 9 | 0G/9B | $8.4315 | +0.09% | 1↑ 0↓of 1 | — | 1 |
| ARMAS PHARMACEUTICALS INC. | 9 | 9G/0B | $9.0112 | +2.34% | 5↑ 3↓of 8 | — | 1 |
| Gabar Health Sciences Corp. | 8 | 8G/0B | $0.2666 | — | — | 1 | — |
| Medimetriks Pharmaceuticals Inc. | 8 | 4G/4B | $40.7680 | -2.72% | 1↑ 3↓of 4 | — | 4 |
| Cephalon, LLC | 8 | 0G/8B | $47.2432 | +0.12% | 2↑ 0↓of 2 | — | 2 |
| Neurelis, Inc | 8 | 0G/8B | $366.21 | -0.01% | 2↑ 2↓of 4 | — | — |
| Avenacy Inc. | 8 | 8G/0B | $30.6017 | +0.05% | 2↑ 3↓of 5 | — | — |
| BioDelivery Sciences International Inc | 8 | 0G/8B | $14.1526 | -0.03% | 2↑ 5↓of 7 | — | — |
| Omnivium Pharmaceuticals LLC | 8 | 8G/0B | $1.8190 | -3.91% | 1↑ 4↓of 5 | — | 2 |
| Harrow Eye, LLC | 8 | 0G/8B | $91.4265 | -0.07% | 0↑ 4↓of 4 | — | 2 |
| Validus Pharmaceuticals LLC | 8 | 0G/8B | $2.5625 | -0.03% | 3↑ 3↓of 6 | — | 3 |
| Ferring Pharmaceuticals Inc. | 8 | 1G/7B | $168.11 | -0.07% | 1↑ 1↓of 2 | — | 1 |
| Teva Respiratory, LLC | 8 | 0G/8B | $131.24 | — | 1↑ 2↓of 3 | — | 2 |
| Medexus Pharma Inc. | 7 | 0G/7B | $542.21 | — | — | — | 1 |
| Fougera Pharmaceuticals Inc. | 7 | 7G/0B | $2.0165 | -0.19% | 2↑ 3↓of 5 | — | — |
| Catalyst Pharmaceuticals, Inc. | 7 | 0G/7B | $31.3860 | -0.06% | 2↑ 5↓of 7 | — | — |
| Indivior Inc. | 7 | 0G/7B | $705.37 | -0.04% | 1↑ 6↓of 7 | — | 1 |
| OWP Pharmaceuticals, Inc. | 7 | 7G/0B | $4.1563 | -0.88% | 1↑ 4↓of 5 | — | 1 |
| Daiichi Sankyo Inc. | 7 | 0G/7B | $14.6260 | — | — | — | 1 |
| Advanz Pharma (US) Corp. | 7 | 0G/7B | $12.8504 | — | — | — | 3 |
| U.S. Pharmaceutical Corporation | 7 | 0G/7B | $0.7322 | -0.02% | 2↑ 3↓of 5 | — | — |
| Sebela Pharmaceuticals Inc. | 7 | 0G/7B | $21.1074 | -0.13% | 0↑ 1↓of 1 | — | 1 |
| Santarus Inc. | 7 | 0G/7B | $81.9991 | — | — | — | 3 |
| Vanda Pharmaceuticals Inc. | 7 | 0G/7B | $41.0313 | +0.06% | 4↑ 3↓of 7 | — | — |
| Digestive Care, Inc. | 6 | 0G/6B | $5.3400 | +0.14% | 4↑ 0↓of 4 | — | — |
| Melinta Therapeutics, LLC | 6 | 0G/6B | $25.4657 | — | — | — | 1 |
| Mannkind Corporation | 6 | 0G/6B | $10.4065 | — | — | — | — |
| PureTek Corporation | 6 | 6G/0B | $0.9008 | -0.81% | 0↑ 2↓of 2 | — | — |
| Foundation Consumer Healthcare LLC | 6 | 4G/2B | $14.6070 | — | — | — | 1 |
| Thea Pharma Inc. | 6 | 0G/6B | $29.0998 | -0.07% | 0↑ 5↓of 5 | — | 3 |
| Xeris Pharmaceuticals, Inc. | 6 | 0G/6B | $1869.58 | +0.12% | 4↑ 1↓of 5 | — | — |
| Hisun Pharmaceuticals USA Inc. | 6 | 6G/0B | $1.6187 | -1.23% | 1↑ 3↓of 4 | 1 | — |
| BioComp Pharma Inc. | 6 | 6G/0B | $0.9926 | +0.25% | 2↑ 3↓of 5 | — | — |
| Orexo US, Inc. | 6 | 0G/6B | $11.4105 | -0.02% | 1↑ 5↓of 6 | — | — |
| Vivus LLC | 6 | 0G/6B | $5.2303 | — | — | — | — |
| Kesin Pharma Corporation | 6 | 5G/1B | $0.6353 | +2.71% | 2↑ 2↓of 4 | — | — |
| Allegis Pharmaceuticals, LLC | 6 | 6G/0B | $6.9664 | -1.63% | 0↑ 4↓of 4 | — | — |
| INA Pharmaceutics Inc | 5 | 4G/1B | $8.8186 | -6.13% | 0↑ 2↓of 2 | — | 1 |
| Coloplast Manufacturing US, LLC | 5 | 4G/1B | $0.0663 | — | — | — | — |
| Covis Pharma US, Inc | 5 | 0G/5B | $27.6016 | -0.04% | 0↑ 3↓of 3 | — | 1 |
| Brookfield Pharmaceuticals, LLC | 5 | 5G/0B | $0.4933 | — | — | — | — |
| Hikma Specialty USA Inc. | 5 | 0G/5B | $17.0886 | +0.04% | 4↑ 0↓of 4 | — | 1 |
| Biocon Biologics Inc. | 5 | 2G/3B | $649.94 | -0.07% | 0↑ 4↓of 4 | — | — |
| Ironshore Pharmaceuticals Inc. | 5 | 0G/5B | $15.4008 | -0.02% | 1↑ 3↓of 4 | — | 1 |
| LEO Pharma Inc. | 5 | 0G/5B | $17.6635 | +0.08% | 2↑ 0↓of 2 | — | 2 |
| Leadiant Biosciences, Inc. | 5 | 0G/5B | $0.6160 | — | — | — | — |
| Oliva Therapeutics, LLC | 5 | 4G/1B | $0.3944 | +3.20% | 4↑ 0↓of 4 | — | — |
| Patriot Pharmaceuticals | 5 | 5G/0B | $14.0812 | +2.18% | 1↑ 1↓of 2 | — | 1 |
| Pharmaceutical Associates, Inc. | 5 | 5G/0B | $0.1915 | +2.34% | 2↑ 0↓of 2 | — | — |
| Provepharm Inc. | 5 | 5G/0B | $24.9833 | +2.14% | 2↑ 0↓of 2 | — | — |
| Rising Health, LLC | 5 | 5G/0B | $0.0878 | -0.86% | 3↑ 2↓of 5 | — | — |
| The J. Molner Company LLC | 5 | 5G/0B | $0.6052 | +4.39% | 2↑ 2↓of 4 | — | 1 |
| VGYAAN Pharmaceuticals LLC | 5 | 5G/0B | $52.5722 | — | — | — | 2 |
| Immunex Corporation | 4 | 0G/4B | $2082.87 | +0.02% | 2↑ 0↓of 2 | — | — |
| Hillestad Pharmaceuticals USA | 4 | 4G/0B | $0.2438 | -1.44% | 0↑ 2↓of 2 | — | — |
| Oncor Pharmaceuticals | 4 | 4G/0B | $0.1305 | +0.36% | 2↑ 2↓of 4 | — | — |
| Acertis Pharmaceuticals, LLC | 4 | 2G/2B | $15.0808 | +0.50% | 2↑ 1↓of 3 | — | 2 |
| Braintree Laboratories, Inc. | 4 | 0G/4B | $17.1791 | -0.01% | 0↑ 1↓of 1 | — | — |
| Aprecia Pharmaceuticals, LLC | 4 | 0G/4B | $10.2726 | — | — | — | 1 |
| Medicure International Inc | 4 | 0G/4B | $7.4085 | -0.03% | 0↑ 4↓of 4 | — | — |
| GenBioPro, Inc. | 4 | 4G/0B | $0.7254 | -1.03% | 0↑ 3↓of 3 | — | — |
| Quinn Pharmaceuticals | 4 | 4G/0B | $0.1636 | -1.49% | 0↑ 4↓of 4 | — | — |
| GM Pharmaceuticals, INC | 4 | 1G/3B | $0.1829 | — | — | — | — |
| Fresenius Kabi, LLC | 4 | 4G/0B | $4.4165 | — | — | — | — |
| Phathom Pharmaceuticals Inc. | 4 | 0G/4B | $14.9609 | +0.09% | 2↑ 1↓of 3 | — | — |
| TOLMAR Inc. | 4 | 1G/3B | $8.9846 | -0.55% | 2↑ 1↓of 3 | — | — |
| Vista Pharmaceuticals, Inc. | 4 | 4G/0B | $0.0788 | — | — | — | 1 |
| Duchesnay USA, Inc. | 4 | 0G/4B | $7.2853 | -0.02% | 0↑ 1↓of 1 | — | 1 |
| Cameron Pharmaceuticals | 4 | 4G/0B | $1.3403 | +0.04% | 2↑ 2↓of 4 | — | — |
| Dista Products Company | 4 | 0G/4B | $16.4383 | — | — | — | 1 |
| Beach Products, Inc. | 4 | 4G/0B | $0.4349 | +9.43% | 2↑ 2↓of 4 | — | — |
| ACI Healthcare USA Inc. | 4 | 4G/0B | $0.0366 | +1.81% | 2↑ 0↓of 2 | — | — |
| SDA Laboratories, Inc. | 4 | 4G/0B | $0.0285 | — | — | — | — |
| Marnel Pharmaceuticals, Inc. | 3 | 3G/0B | $2.2079 | — | — | — | — |
| BF ASCHER AND CO INC | 3 | 1G/2B | $0.0589 | — | — | — | — |
| Lundbeck Pharmaceuticals LLC | 3 | 0G/3B | $34.1047 | -0.03% | 0↑ 3↓of 3 | — | 1 |
| Long Grove Pharmaceuticals, LLC | 3 | 3G/0B | $5.3450 | -0.84% | 1↑ 2↓of 3 | — | — |
| Vifor Pharma, Inc. | 3 | 0G/3B | $37.8205 | +0.02% | 1↑ 0↓of 1 | — | — |
| Lifsa Drugs LLC | 3 | 3G/0B | $9.8841 | — | — | — | 1 |
| Lexicon Pharmaceuticals, Inc. | 3 | 0G/3B | $20.2187 | -0.19% | 0↑ 2↓of 2 | — | — |
| Laser Pharmaceuticals, LLC | 3 | 3G/0B | $1.0092 | — | — | — | 1 |
| Intra-Cellular Therapies, Inc | 3 | 0G/3B | $57.2435 | -0.03% | 0↑ 3↓of 3 | — | — |
| WOMENS CHOICE PHARMACEUTICALS LLC | 3 | 1G/2B | $3.1567 | — | — | — | — |
| West-Ward Pharmaceuticals Corp | 3 | 3G/0B | $0.2997 | — | — | — | 1 |
| Greenstone LLC | 3 | 3G/0B | $0.9267 | -3.50% | 0↑ 2↓of 2 | — | — |
| Genzyme Corporation | 3 | 0G/3B | $13.3447 | — | — | — | 1 |
| GRIFOLS USA, LLC | 3 | 0G/3B | $3.5465 | — | — | — | — |
| ALK-Abello A S | 3 | 0G/3B | $11.7323 | -0.02% | 1↑ 2↓of 3 | — | — |
| CIMA LABS INC. | 3 | 3G/0B | $0.3153 | +1.23% | 1↑ 1↓of 2 | — | — |
| Cumberland Pharmaceuticals Inc. | 3 | 0G/3B | $235.33 | +0.01% | 1↑ 0↓of 1 | — | — |
| Savage Laboratories a division of Fougera Pharmaceuticals Inc. | 3 | 0G/3B | $1.6275 | -0.03% | 0↑ 1↓of 1 | — | — |
| CDMA | 3 | 3G/0B | $0.0138 | -0.66% | 1↑ 2↓of 3 | — | — |
| Royal Pharmaceuticals | 3 | 0G/3B | $0.5360 | — | — | — | — |
| RedHill Biopharma Ltd | 3 | 0G/3B | $11.3579 | -0.09% | 0↑ 3↓of 3 | — | — |
| Aquestive Therapeutics | 3 | 0G/3B | $38.1963 | — | — | — | 1 |
| Affordable Pharmaceuticals, LLC | 3 | 3G/0B | $0.0342 | -2.29% | 1↑ 2↓of 3 | — | — |
| Quest Products, LLC | 3 | 0G/3B | $0.3817 | +1.85% | 2↑ 0↓of 2 | — | 1 |
| Teva Women's Health, Inc. | 3 | 0G/3B | $36.1443 | -0.11% | 0↑ 1↓of 1 | — | 1 |
| Capital Pharma | 3 | 0G/3B | $0.2381 | — | — | — | — |
| Puro Pharma Inc. | 3 | 3G/0B | $0.8105 | -5.50% | 0↑ 3↓of 3 | — | 1 |
| Piramal Critical Care | 3 | 3G/0B | $1.4163 | +6.24% | 1↑ 0↓of 1 | — | — |
| kaleo, Inc | 3 | 0G/3B | $309.59 | — | — | — | — |
| Phlow Corporation | 3 | 3G/0B | $0.5093 | +4.59% | 2↑ 0↓of 2 | — | — |
| Arcutis Biotherapeutics, Inc. | 3 | 0G/3B | $15.3848 | +0.01% | 1↑ 1↓of 2 | — | 1 |
| OPKO Pharmaceuticals LLC | 3 | 0G/3B | $40.4515 | -0.03% | 0↑ 1↓of 1 | — | — |
| Aucta Pharmaceuticals, Inc. | 3 | 0G/3B | $21.4810 | — | — | — | 1 |
| Neurocrine Biosciences, Inc. | 3 | 0G/3B | $275.20 | — | — | — | — |
| Millicent US, Inc. | 3 | 0G/3B | $602.15 | +0.04% | 2↑ 1↓of 3 | — | — |
| Adare Pharmaceuticals Inc | 3 | 3G/0B | $0.1265 | — | — | — | — |
| Corium, LLC. | 3 | 0G/3B | $14.4137 | -0.04% | 0↑ 2↓of 2 | — | — |
| Valinor Pharma, LLC | 3 | 0G/3B | $14.5968 | -0.10% | 0↑ 3↓of 3 | — | — |